About
Enzyme Replacement Therapy
Areas of Focus
Categories
Biologics & BiopharmaceuticalGene Therapy, RNA & Peptide TherapyBoston & New England
Clinical Trials (10)
View allTotal Trials
10
As Lead Sponsor
10
As Collaborator
0
Total Enrollment
1,323
By Phase
PHASE2: 2PHASE1: 2PHASE3: 1PHASE1/PHASE2: 2
By Status
COMPLETED: 5RECRUITING: 3WITHDRAWN: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline10 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
Today
Hover over trial bars to see details
Recent Trials
NCT06739980Lead Sponsor
The ENABLE Study: Safety and Efficacy Study of INZ-701 in Patients With ENPP1 Deficiency
PHASE2Withdrawn
Started: Jan 31, 2025 · Completed: Mar 31, 2028
NCT06302439Lead Sponsor
PROPEL - A Prospective Observational Patient Registry to Evaluate ENPP1 and ABCC6 Deficiency
N/ARecruiting
1,000 participants
Started: Jul 25, 2024 · Completed: May 31, 2034
NCT06462547Lead Sponsor
ADAPT Study: Long-term Safety Study of INZ-701 in Patients With ENPP1 Deficiency and ABCC6 Deficiency
PHASE2Recruiting
200 participants
Started: Jun 19, 2024 · Completed: Dec 31, 2030
NCT06283589Lead Sponsor
The SEAPORT 1 Study: Evaluation of the Safety and Tolerability of INZ-701 in Adults With End-Stage Kidney Disease Undergoing Hemodialysis
PHASE1Completed
11 participants
Started: Feb 12, 2024 · Completed: Dec 13, 2024
NCT06046820Lead Sponsor
The ENERGY 3 Study: Evaluation of Efficacy and Safety of INZ-701 in Children With ENPP1 Deficiency
PHASE3Active, not recruiting
27 participants
Started: Nov 5, 2023 · Completed: Feb 28, 2026
Locations (1)
Headquarters
Boston, MA, United States
Map
Loading map...